Cancer

Closing in on advanced prostate cancer

In most cases, prostate cancer is cured by surgery and/or radiotherapy. However, 20 percent of patients will need treatment to remove tumour cells but this treatment ceases to be effective after two or three years and the ...

Cancer

Heterogeneity of PET/CT imaging phenotype prognostic in mCRPC

(HealthDay)—Metastatic castration-resistant prostate cancer (mCRPC) has heterogeneity in positron emission tomography (PET)/computed tomography (CT) imaging phenotype, which has clinical relevance, according to a study ...

Medical research

Androgen plays key role in ovarian development

Scientists have discovered that the male androgen hormone is an important element in the ovarian development of female chicken embryos, more so than in the development of male testes.

Cancer

Gene mutation found to drive prostate cancer subtype

A newly discovered genetic mutation that is found in a subtype of prostate cancer is integral to the disease's development and growth, according to research from Weill Cornell Medicine scientists. Their findings could pave ...

page 2 from 10